Search

Your search keyword '"McDowell, Kirsty"' showing total 29 results
Start Over Author "McDowell, Kirsty" Search Limiters Academic (Peer-Reviewed) Journals
29 results on '"McDowell, Kirsty"'

2. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study

Author

Dunning, Jake, Fink, Douglas L, Milligan, Iain D, Luintel, Akish, Rodger, Alison J, Bhagani, Sanjay R, Lamb, Lucy E, Moores, Rachel C, Lee, Simon F K, Brown, Colin S, Hopkins, Susan, Mepham, Stephen, Warren, Simon, Molloy, Aoife, Cropley, Ian, Kew, Alex, Karunaharan, Natasha, Scobie, Antonia, Hart, Jennifer, Irish, Dianne, Haque, Tanzina, Jalal, Hamid, Smith, Robin, Mack, Damien, Barber, Tristan, Burns, Fiona, Miller, Robert, Hamlyn, Eleanor, Simoes, Pedro, Athan, Breda, Abrahamsen, Jennifer, Joyce, Jessica, Taylor, Caroline, Reddecliffe, Sally, Miller, Chloe, Reeve, Brooke, Kingston, Hugh, Crocker-Buque, Tim, Massie, Nicolas, Dhariwal, Ankush, Jayakumar, Angelina, Hammond, Robert, Bramley, Alexandra, Kanitkar, Tanmay, Maynard-Smith, Laura, Gil, Eliza, O'Connor, Cavan, Cocker, Derek, Spicer, Wendy, Lanzman, Marisa, Thacker, Meera, Anorson, Zoe O, Patel, Dharmesh, Williams, Alan, Houlihan, Catherine F, Wakerley, Dominic, Gordon, Claire N, Callaby, Helen, Bailey, Daniel J, Furneaux, Jenna, Bown, Abbie M, Truelove, Elizabeth J, Killip, Marian J, Jackson, David, Beetar-King, Tracy L B, Arnold, Ulrike M V, Strachan, Rhea M, Matthew, Jones, Matthew, Hannah J, Osborne, Jane C, Rampling, Tommy, Vipond, Richard, Gibney, Barry, Owen, Jodie, Bond, Helena, Beynon, Will, Hunter, Michael, McCorry, Louise, Emerson, Carol, Quah, Say, Todd, Suzanne, McCarty, Emma, Walker, Eoin, Feeney, Susan, Curran, Tanya, Li, Kathy, Mullan, JD, Jackson, Kate, Nelson, Peter, Lewis, Kevin, McNicol, Mark, Pratt, Marcus, Smith, Anna, Vos, Erin, Alsalemee, Fahad, O Leary, Daniel, Canny, John, McGinnity, Katherine, Culbert, Carly, McDowell, Conor, McQuillan, Cathy, Jeong, Eunjin, Glass, Lynsey, Dyche, Jessica, McClean, Paula, Stewart, Rebecca, Ursolino, Harold, Perry, Melissa, McCormick, Hannah, Lim, Eleanor Y, Gkrania-Klotsas, Effrossyni, Bracchi, Margherita, Heskin, Joseph, Brown, Nicklas, Juniper, Thomas, Mora-Peris, Borja, Dalla-Pria, Alessia, Mackie, Nicola, Garvey, Lucy, Winston, Alan, Cooke, Graham, Nelson, Mark, Kilbride, Emer, Elbishi, Ala, Kerrigan, William, Silva, Joshua, Gohil, Jesal, Payagala, Sasha, Walters, Yasmin, Smith, Joanna, Goodfellow, Jonathan, Lyons, Kitty, Tung, Hsiu, Patel, Kinjal, Henderson, Merle, Butler, Michael, Peres, Edu, Silva Carvalho, Taiana, Joly, Antoine, Dickinson, Molly, Moore, Luke S P, Mughal, Nabeela, Hughes, Stephen, Chitlangia, Shrada, Viramgana, Priyanka, Byrne, Ruth, Randell, Paul, Strangis, Luigi, Poveda, Nicola, Bovey, Deborah, Richardson, Poppy, Heaslip, Vivian, Higgs, Christopher, Boffito, Marta, Girometti, Nicolo, Whitlock, Gary, Tittle, Victoria, Jones, Rachel, Rayment, Michael, Scott, Christopher, Asboe, David, Pond, Marcus, Muir, David, Rathish, Balram, O'Hara, Geraldine, Abeywickrema, Movin, Bailey, Sarah-Lou, Boyd, Sara E, Da Silva Fontoura, Dayana, Daunt, Anna, Mason, Claire Y, Murphy, Jamie, Naidu, Vasanth V, Patel, Aatish, Pley, Caitlin, Redmore, Ethan, Sharrocks, Katherine, Snell, Luke B, Sundramoorthi, Rohan, Tam, Jerry C H, Brown, Aisling, Douthwaite, Sam, Goodman, Anna, Nebbia, Gaia, Newsholme, William, Price, Nicholas, Shaw, Emily, Salam, Alex, van Nispen tot Pannerden, Claire, Winslow, Helen, Bilinska, Julia, Keegan, Sarah, Coleman, Harry, Doctor, Jessica, Moini, Nasreen, Chilton, Daniella, Haidari, Golaleh, Simons, Rebecca, Kulasegaram, Rajababu, Larbalestier, Nick, Nori, Achyuta, Potter, Jack R, Tuudah, Cecilia, Wade, Paul, Travers, Alexandra, Dunford, Sarah, Greenwood, Joshua, Oledimmah, Georgina, Gyampo, Lesley, SA Pinto, Pedro, Muse, AbdulKadir, Parker, Zoe, Alexander, Charlotte, Khan, Alexander, Ajayi, Medinat, Baltazar, Abigail, Sharella, Davis, Hersi, Nasra, Nguyen, Thuy, Timbo, Rugiatu, Jalloh, Ismail, Bryan, Susan, Clarke, Patricia, Kerr, Marcia, Amedu, Fidelis, BohoBonaba, Maria, Haque, Sarah, Howson, Michelle, Tambilawan, Norbai, Yupanqui Estay, Soledad, Bangura, Hawanatu, Gideon, Tseday, Jerome-oboh, Damilola, Tetteh, Linda, Nwagu, Chioma, Agbaglah, Viwoalo, Narag, Nona, Zaveri, Mahima, Ni Luanaigh, Maedhbh, Keane, Peggy, Peters, Joanna R, Rimmer, Stephanie, Abbara, Aula, Dosekun, Olamide, Bolland, Mhairi, Stafford, Adam, Saleh, Dina, Sheridan, Rhianna, Davies, Ella, Sun, Kristi, Gilchrist, Mark, Kukadia, Priti, Embrahimsa, Muhammed, Chiu, Christopher, Taylor, Lauren, Short, Charlotte, Alagratnam, Jasmini, Jayaweera, Iresh, Gundugola, Kavitha, Payne, Lara V S, Mody, Nisha, Quinn, Killian, Nic Fhogartaigh, Caoimhe, Kaur, Nivenjit, Bholah, Salmaan, Kantha, Kajann, Youngs, Jonathan, Lampejo, Temi, Pitto, Nicholas, Lawrence, David S, Middleditch, Holly, Dominguez-Dominguez, Lourdes, Ratnappuli, Ayoma, Al-Hashimi, Sara, Oliveira, Amelia, Ottaway, Zoe, Mulka, Larissa, Hodgson, Bethany, Lewthwaite, Penny, Neary, Anne M, Downey, Michael R, Lucy, Danielle C, McCallum, Craig I, Beadsworth, Michael, Ratcliffe, Libuse, Fletcher, Tom E, Davies, Gerry, Wong, Nicholas, Aston, Stephen, Wingfield, Thomas E, Blanchard, Thomas, Hine, Paul, Lester, Rebecca, Woolley, Stephen D, Gould, Susie, Smith, Christopher, Abouyannis, Michael, Atomode, Abolaji, Cruise, James, Samual, Merna, Scott, Nicola, Srirathan, Vino, Lewis, Joseph, Richards, Lauren, Cummings, Mary-Ann, Gillan, Emily, Peers, Rebecca, Tickle, Amy, Keating, Grace, Chinyanda, Tendi, Sanchez, Mav, Harrison, Daniel, Hoyle, Metcalfe, Ben, Taylor, Jennifer, Johnson, Nicky, Kelle, Neil, McDowell, Kirsty, Richardson, Ian, Saguidan, Monette, Farmer, Nicky, Gillespie, Angella, Willoughby, Shay, Parker, Samantha, Avulan, Shamseena, Arif, Shazia, Marshall, Suzanne, Carlisle, David, Rezaei, Mohsen, Booth, Angela, Watts, Joanne, Tremarco, Lauren, Jeyanayagam, Priyanga, Ubochi, Odinaka, Vagianos, Daniel, Richardson, Mark, Jarvis, Anthony, Gow, Kyra, Walmsley, Jade, O'keefe, Adam, Smielewska, Anna, Hopkins, Mark, Balane, Fatima, Bradley, Sarah, Corrah, Tumena, Daquiz, Venus, Dugan, Christopher, Elliot, Joshua, Foley, Fiona, Friday, Dawn, Gamit, May, Garner, David, Gokani, Karishma, John, Laurence, Joseph, Deepa, Khan, Nuzhath, Mamuyac, Cherifer, McGregor, Alastair, McSorley, John, Parris, Victoria, Rubinstein, Luciana, Rycroft, Julian, Salinas, Kelcy, Salinas, Jason, Sebatian, Jency, Smith, Melanie, Tejero Garcia, Marina, Ume, Uchenna, Vicentine, Margarete, Wallis, Gabriel, Sturdy, Ann, Whittington, Ashley, Jacobs, Nathan, Johnson, Leann, Bonington, Alec, Uriel, Alison, Ustianowski, Andrew, Dancso, Balazs, Hogan, Celia, van Halsema, Clare, Vilar, F Javier, Devine, Karen, Ajdukiewicz, Katherine, Rajendran, Rajesh, Ghosh, Samit, Riste, Michael, Machin, Nicholas, Babu, Chitra, Ahmad, Shazaad, Obeng, Dorcas, Dave, Farnaz, Conolley, Gavin, Thompson, Joseph, Tickell-Painter, Maya, Chakravorty, Prasun, Pringle, Rachel, Zafar, Mohammad R, Lawrence, Sarah, Sanchez-Gonzalez, Amada, Fernandez, Cristina, Goodwin, Lynsey, Carey, David, Howarth-Maddison, Molly, Moody, Samuel, Upton, Rebecca, Apthorp, Christina, Murray, Charlotte, Salthouse, Kirstie, Nadeem, Sabah, Ridley, Grant, White, Francesca, Brown, Andrew, Lawless, Michael, Mohamed, Mohamed, Mulligan, Robert, Belfield, Amy, Brolly, Jacob, Calderon, Maria, Cheveau, James, Cullinan, Milo, Garrad, Sophie, Griffiths, Will, Ireland, Aidan, Ireland, Peter, Milne, Charlotte, Nwajiugo, Paul, Quartey, John, Ghavami-Kia, Bijan, Duncan, Chris, Evans, Adam, Hunter, Ewan, Price, Ashley, Schmid, Matthias, Schwab, Uli, Taha, Yusri, Payne, Brendan, Elliott, Ivo A M, Crowe, Stewart, Woodrow, Charles J, Karageorgopoulos, Drosos E, Davis, Peter J, Lord, Emily, Bannister, Oliver J, Dagens, Andrew B, Harrison, Thomas, Cole, Joby, Tunbridge, Anne, Choudry, Saher, Telfer, Adam, Jhibril, Ihsan, Atta, Syed N, Stone, Ben, Evans, Cariad, Ankcorn, Mike, Akili, Suha, Yavuz, Mehmet, Goodall, Vicky, Farrow, Sam, Mountford, Georgina, Cusack, Tomas-Paul, Beard, Kate, Sutton, Julian, Clark, Tristan, Mason, Annette, Vickers, Mike, Macallan, Derek, Bicanic, Tihana, Houston, Angela, Pope, Cassie, Tan, NgeeKeong, Ward, Christopher, Jones, Imogen, Banerjee, Rishi, Cohen, Jonathan, Emonts-le Clercq, Marieke, Porter, David, Riordan, Andrew, Sinha, Ruchi, Whittaker, Elizabeth, Beynon, William, Heskin, Jospeh, Milligan, Iain, Payne, Lara, AI Payne, Brendan, Elliott, Ivo AM, and Beard, Katie

Published
2023
Full Text
View/download PDF

3. Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction

Author

McDowell, Kirsty, primary, Kondo, Toru, additional, Talebi, Atefeh, additional, Teh, Ken, additional, Bachus, Erasmus, additional, de Boer, Rudolf A., additional, Campbell, Ross T., additional, Claggett, Brian, additional, Desai, Ashkay S., additional, Docherty, Kieran F., additional, Hernandez, Adrian F., additional, Inzucchi, Silvio E., additional, Kosiborod, Mikhail N., additional, Lam, Carolyn S. P., additional, Martinez, Felipe, additional, Simpson, Joanne, additional, Vaduganathan, Muthiah, additional, Jhund, Pardeep S., additional, Solomon, Scott D., additional, and McMurray, John J. V., additional

Published
2024
Full Text
View/download PDF

6. Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

Author

Butt, Jawad H., primary, McDowell, Kirsty, additional, Kondo, Toru, additional, Desai, Akshay S., additional, Lefkowitz, Martin P., additional, Packer, Milton, additional, Petrie, Mark C., additional, Pfeffer, Marc A., additional, Rouleau, Jean L., additional, Vaduganathan, Muthiah, additional, Zile, Michael R., additional, Jhund, Pardeep S., additional, Køber, Lars, additional, Solomon, Scott, additional, and McMurray, John J.V., additional

Published
2023
Full Text
View/download PDF

7. Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure

Author

Docherty, Kieran F., primary, McDowell, Kirsty, additional, Welsh, Paul, additional, Osmanska, Joanna, additional, Anand, Inder, additional, de Boer, Rudolf A., additional, Køber, Lars, additional, Kosiborod, Mikhail N., additional, Martinez, Felipe A., additional, O’Meara, Eileen, additional, Ponikowski, Piotr, additional, Schou, Morten, additional, Berg, David D., additional, Sabatine, Marc S., additional, Morrow, David A., additional, Jarolim, Petr, additional, Hammarstedt, Ann, additional, Sjöstrand, Mikaela, additional, Langkilde, Anna Maria, additional, Solomon, Scott D., additional, Sattar, Naveed, additional, Jhund, Pardeep S., additional, and McMurray, John J.V., additional

Published
2023
Full Text
View/download PDF

8. Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan.

Author

Butt, Jawad H., McDowell, Kirsty, Kondo, Toru, Desai, Akshay S., Lefkowitz, Martin P., Packer, Milton, Petrie, Mark C., Pfeffer, Marc A., Rouleau, Jean L., Vaduganathan, Muthiah, Zile, Michael R., Jhund, Pardeep S., Køber, Lars, Solomon, Scott, and McMurray, John J.V.

Subjects
BRAIN natriuretic factor, ERYTHROCYTES, HEART failure, VENTRICULAR ejection fraction, VALSARTAN
Abstract

Aims: Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about its prognostic significance in HF with preserved ejection fraction. We examined the relationship between RDW and outcomes and the effect of sacubitril/valsartan, compared with valsartan, on RDW and clinical outcomes in PARAGON‐HF. Methods and results: PARAGON‐HF enrolled patients with a left ventricular ejection fraction of ≥45%, structural heart disease, and elevated N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). The primary endpoint was a composite of total HF hospitalizations and cardiovascular deaths. Median RDW at randomization was 14.1% (interquartile range 13.5–15.0%). Patients with higher RDW levels were more often men and had more comorbidity, a higher heart rate and NT‐proBNP concentration, more advanced New York Heart Association class, and worse Kansas City Cardiomyopathy Questionnaire scores. There was a graded relationship between quartiles of RDW at randomization and the primary endpoint, with a significantly higher risk associated with increasing RDW, even after adjustment for NT‐proBNP and other prognostic variables {Quartile 1, reference; Quartile 2, rate ratio 1.03 [95% confidence interval (CI) 0.83 to 1.28]; Quartile 3, 1.25 [1.01 to 1.54]; Quartile 4, 1.70 [1.39 to 2.08]}. This association was seen for each of the secondary outcomes, including cardiovascular and all‐cause death. Compared with valsartan, sacubitril/valsartan reduced RDW at 48 weeks [mean change −0.09 (95% CI −0.15 to −0.02)]. The effect of sacubitril/valsartan vs. valsartan was not significantly modified by RDW levels at randomization. Conclusions: RDW, a routinely available and inexpensive biomarker, provides incremental prognostic information when added to established predictors. Compared with valsartan, sacubitril/valsartan led to a small reduction in RDW. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.

Author

McDowell, Kirsty, Adamson, Carly, Jackson, Colette, Campbell, Ross, Welsh, Paul, Petrie, Mark C., McMurray, John J.V., Jhund, Pardeep S., and Herring, Neil

Subjects
*NEUROPEPTIDE Y, *HEART failure, *CARDIAC pacing, *RECURSIVE partitioning, CARDIOVASCULAR disease related mortality
Abstract

Aims: Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart and is released alongside norepinephrine following prolonged sympathetic activation, a process that is implicated in the pathophysiology of heart failure (HF). In patients with severely impaired left ventricular ejection fraction (LVEF) undergoing cardiac resynchronization therapy, higher levels of NPY measured in coronary sinus blood, are associated with poorer outcome. The aim was to examine the association of peripheral venous NPY levels and outcomes in a HF population with a range of LVEF, using a highly sensitive and specific assay. Methods and results: The association between NPY and the composite outcome of cardiovascular death or HF hospitalization, its components, and all‐cause mortality was examined using Cox regression analyses among 833 patients using a threshold of elevated NPY identified through binary recursive partitioning adjusted for prognostic variables including estimated glomerular filtration rate (eGFR), ejection fraction and B‐type natriuretic peptide (BNP). The mean value of NPY was 25.8 ± 18.2 pg/ml. Patients with high NPY levels (≥29 pg/ml) compared with low values were older (73 ± 10 vs. 71 ± 11 years), more often male (58.5% vs. 55.6%), had higher BNP levels (583 [261–1096] vs. 440 [227–829] pg/ml), lower eGFR (46.4 ± 13.9 vs. 52.4 ± 11.7 ml/min/1.73 m2), and were more often treated with diuretics. There was no associated risk of HF hospitalization with NPY levels ≥29 vs. <29 pg/ml. Higher NPY levels were associated with a greater risk of cardiovascular and all‐cause death (adjusted hazard ratio 1.56 [95% confidence interval 1.21–2.10], p = 0.003 and 1.30 [1.04–1.62], p = 0.02, respectively). There was no associated risk of HF hospitalization with higher NPY levels. Conclusions: Peripherally measured NPY is an independent predictor of all‐cause and cardiovascular death even after adjustment for other prognostic variables, including BNP. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Incremental prognostic value of biomarkers in PARADIGM‐HF

Author

McDowell, Kirsty, primary, Campbell, Ross, additional, Simpson, Joanne, additional, Cunningham, Jonathan W., additional, Desai, Akshay S., additional, Jhund, Pardeep S, additional, Lefkowitz, Martin P., additional, Rouleau, Jean L., additional, Swedberg, Karl, additional, Zile, Michael R., additional, Solomon, Scott D., additional, Packer, Milton, additional, and McMurray, John J.V., additional

Published
2023
Full Text
View/download PDF

11. RED CELL DISTRIBUTION WIDTH IS AN INDEPENDENT PREDICTOR OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: AN ANALYSIS OF THE PARAGON-HF TRIAL

Author

Butt, Jawad Haider, primary, Jhund, Pardeep, additional, Mcdowell, Kirsty, additional, K⊘ber, Lars, additional, Pfeffer, Marc A., additional, Rouleau, Jean L., additional, Zile, Michael R., additional, Petrie, Mark, additional, Desai, Akshay S., additional, Solomon, Scott D., additional, Packer, Milton, additional, and McMurray, John J.V., additional

Published
2023
Full Text
View/download PDF

12. THE IMPORTANCE OF BLOOD UREA NITROGEN TO CREATININE RATIO IN PATIENTS WITH HFPEF AND HFREF

Author

Tolomeo, Paolo, primary, Kondo, Toru, additional, Butt, Jawad Haider, additional, Desai, Akshay S., additional, Jhund, Pardeep, additional, K⊘ber, Lars, additional, Kosiborod, Mikhail, additional, mcdowell, kirsty, additional, Packer, Milton, additional, Petrie, Mark, additional, Rouleau, Jean L., additional, Zile, Michael R., additional, Solomon, Scott D., additional, and McMurray, John J.V., additional

Published
2023
Full Text
View/download PDF

13. Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure

Author

Docherty, Kieran F., McDowell, Kirsty, Welsh, Paul, Osmanska, Joanna, Anand, Inder, de Boer, Rudolf A., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., O'Meara, Eileen, Ponikowski, Piotr, Schou, Morten, Berg, David D., Sabatine, Marc S., Morrow, David A., Jarolim, Petr, Hammarstedt, Ann, Sjöstrand, Mikaela, Langkilde, Anna Maria, Solomon, Scott D., Sattar, Naveed, Jhund, Pardeep S., McMurray, John J. V., Docherty, Kieran F., McDowell, Kirsty, Welsh, Paul, Osmanska, Joanna, Anand, Inder, de Boer, Rudolf A., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., O'Meara, Eileen, Ponikowski, Piotr, Schou, Morten, Berg, David D., Sabatine, Marc S., Morrow, David A., Jarolim, Petr, Hammarstedt, Ann, Sjöstrand, Mikaela, Langkilde, Anna Maria, Solomon, Scott D., Sattar, Naveed, Jhund, Pardeep S., and McMurray, John J. V.

Abstract

Background: Elevated circulating carbohydrate antigen 125 (CA125) is a marker of congestion and a predictor of outcomes in acute heart failure (HF). Less is known about CA125 in chronic ambulatory HF with reduced ejection fraction. Objectives: This study examined the association between baseline CA125 (and changes in CA125) and outcomes in patients with HF with reduced ejection fraction in the DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure; NCT03036124) trial and its relationship with the effect of dapagliflozin. Methods: The primary outcome was a composite of a first episode of worsening HF or cardiovascular death. CA125 was measured at baseline and 12 months following randomization. Results: Median baseline CA125 was 13.04 U/mL (IQR: 8.78-21.13 U/mL) in 3,123 of 4,774 patients with available data. Compared with CA125 ≤35 U/mL (upper limit of normal), patients with CA125 >35 U/mL were at a higher risk of the primary outcome (adjusted HR: 1.59; 95% CI: 1.29-1.96). The adjusted risks of the primary outcome relative to quartile 1 (Q1) (≤8.78 U/mL) were as follow: Q2, 8.79-13.04 U/mL (HR: 0.94; 95% CI: 0.71-1.24); Q3, 13.05-21.13 U/mL (HR: 1.22; 95% CI: 0.94-1.59); Q4, ≥21.14 U/mL (HR: 1.63; 95% CI: 1.28-2.09). The beneficial effect of dapagliflozin compared with placebo on the primary outcome was consistent whether CA125 was analyzed in quartiles (interaction P = 0.13) or as a continuous variable (interaction P = 0.75). The placebo-corrected relative change in CA125 at 12 months was −5.2% (95% CI: −10.6% to 0.5%; P = 0.07). Conclusions: In DAPA-HF, elevated CA125 levels were an independent predictor of the risk of worsening HF or cardiovascular death. Dapagliflozin reduced the risk of worsening HF or cardiovascular death regardless of baseline CA125.

Published
2023

14. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study

Author

Fink, Douglas L, primary, Callaby, Helen, additional, Luintel, Akish, additional, Beynon, William, additional, Bond, Helena, additional, Lim, Eleanor Y, additional, Gkrania-Klotsas, Effrossyni, additional, Heskin, Jospeh, additional, Bracchi, Margherita, additional, Rathish, Balram, additional, Milligan, Iain, additional, O'Hara, Geraldine, additional, Rimmer, Stephanie, additional, Peters, Joanna R, additional, Payne, Lara, additional, Mody, Nisha, additional, Hodgson, Bethany, additional, Lewthwaite, Penny, additional, Lester, Rebecca, additional, Woolley, Stephen D, additional, Sturdy, Ann, additional, Whittington, Ashley, additional, Johnson, Leann, additional, Jacobs, Nathan, additional, Quartey, John, additional, AI Payne, Brendan, additional, Crowe, Stewart, additional, Elliott, Ivo AM, additional, Harrison, Thomas, additional, Cole, Joby, additional, Beard, Katie, additional, Cusack, Tomas-Paul, additional, Jones, Imogen, additional, Banerjee, Rishi, additional, Rampling, Tommy, additional, Dunning, Jake, additional, Fink, Douglas, additional, Rodger, Alison, additional, Bhagani, Sanjay, additional, Lamb, Lucy, additional, Moores, Rachel, additional, Lee, Simon, additional, Brown, Colin, additional, Hopkins, Susan, additional, Mepham, Stephen, additional, Warren, Simon, additional, Molloy, Aoife, additional, Cropley, Ian, additional, Kew, Alex, additional, Karunaharan, Natasha, additional, Scobie, Antonia, additional, Hart, Jennifer, additional, Irish, Dianne, additional, Haque, Tanzina, additional, Jalal, Hamid, additional, Smith, Robin, additional, Mack, Damien, additional, Barber, Tristan, additional, Burns, Fiona, additional, Miller, Robert, additional, Hamlyn, Eleanor, additional, Simoes, Pedro, additional, Athan, Breda, additional, Abrahamsen, Jennifer, additional, Joyce, Jessica, additional, Taylor, Caroline, additional, Reddecliffe, Sally, additional, Miller, Chloe, additional, Reeve, Brooke, additional, Kingston, Hugh, additional, Crocker-Buque, Tim, additional, Massie, Nicolas, additional, Dhariwal, Ankush, additional, Jayakumar, Angelina, additional, Hammond, Robert, additional, Bramley, Alexandra, additional, Kanitkar, Tanmay, additional, Maynard-Smith, Laura, additional, Gil, Eliza, additional, O'Connor, Cavan, additional, Cocker, Derek, additional, Spicer, Wendy, additional, Lanzman, Marisa, additional, Thacker, Meera, additional, Anorson, Zoe, additional, Patel, Dharmesh, additional, Williams, Alan, additional, Houlihan, Catherine, additional, Wakerley, Dominic, additional, Gordon, Claire, additional, Bailey, Daniel, additional, Furneaux, Jenna, additional, Bown, Abbie, additional, Truelove, Elizabeth, additional, Killip, Marian, additional, Jackson, David, additional, Beetar-King, Tracy, additional, Arnold, Ulrike, additional, Strachan, Rhea, additional, Matthew, Jones, additional, Matthew, Hannah, additional, Osborne, Jane, additional, Vipond, Richard, additional, Gibney, Barry, additional, Owen, Jodie, additional, Beynon, Will, additional, Hunter, Michael, additional, McCorry, Louise, additional, Emerson, Carol, additional, Quah, Say, additional, Todd, Suzanne, additional, McCarty, Emma, additional, Walker, Eoin, additional, Feeney, Susan, additional, Curran, Tanya, additional, Li, Kathy, additional, Mullan, JD, additional, Jackson, Kate, additional, Nelson, Peter, additional, Lewis, Kevin, additional, McNicol, Mark, additional, Pratt, Marcus, additional, Smith, Anna, additional, Vos, Erin, additional, Alsalemee, Fahad, additional, O Leary, Daniel, additional, Canny, John, additional, McGinnity, Katherine, additional, Culbert, Carly, additional, McDowell, Conor, additional, McQuillan, Cathy, additional, Jeong, Eunjin, additional, Glass, Lynsey, additional, Dyche, Jessica, additional, McClean, Paula, additional, Stewart, Rebecca, additional, Ursolino, Harold, additional, Perry, Melissa, additional, McCormick, Hannah, additional, Lim, Eleanor, additional, Heskin, Joseph, additional, Brown, Nicklas, additional, Juniper, Thomas, additional, Mora-Peris, Borja, additional, Dalla-Pria, Alessia, additional, Mackie, Nicola, additional, Garvey, Lucy, additional, Winston, Alan, additional, Cooke, Graham, additional, Nelson, Mark, additional, Kilbride, Emer, additional, Elbishi, Ala, additional, Kerrigan, William, additional, Silva, Joshua, additional, Gohil, Jesal, additional, Payagala, Sasha, additional, Walters, Yasmin, additional, Smith, Joanna, additional, Goodfellow, Jonathan, additional, Lyons, Kitty, additional, Tung, Hsiu, additional, Patel, Kinjal, additional, Henderson, Merle, additional, Butler, Michael, additional, Peres, Edu, additional, Silva Carvalho, Taiana, additional, Joly, Antoine, additional, Dickinson, Molly, additional, Moore, Luke, additional, Mughal, Nabeela, additional, Hughes, Stephen, additional, Chitlangia, Shrada, additional, Viramgana, Priyanka, additional, Byrne, Ruth, additional, Randell, Paul, additional, Strangis, Luigi, additional, Poveda, Nicola, additional, Bovey, Deborah, additional, Richardson, Poppy, additional, Heaslip, Vivian, additional, Higgs, Christopher, additional, Boffito, Marta, additional, Girometti, Nicolo, additional, Whitlock, Gary, additional, Tittle, Victoria, additional, Jones, Rachel, additional, Rayment, Michael, additional, Scott, Christopher, additional, Asboe, David, additional, Pond, Marcus, additional, Muir, David, additional, Abeywickrema, Movin, additional, Bailey, Sarah-Lou, additional, Boyd, Sara, additional, Da Silva Fontoura, Dayana, additional, Daunt, Anna, additional, Mason, Claire, additional, Murphy, Jamie, additional, Naidu, Vasanth, additional, Patel, Aatish, additional, Pley, Caitlin, additional, Redmore, Ethan, additional, Sharrocks, Katherine, additional, Snell, Luke, additional, Sundramoorthi, Rohan, additional, Tam, Jerry, additional, Brown, Aisling, additional, Douthwaite, Sam, additional, Goodman, Anna, additional, Nebbia, Gaia, additional, Newsholme, William, additional, Price, Nicholas, additional, Shaw, Emily, additional, Salam, Alex, additional, van Nispen tot Pannerden, Claire, additional, Winslow, Helen, additional, Bilinska, Julia, additional, Keegan, Sarah, additional, Coleman, Harry, additional, Doctor, Jessica, additional, Moini, Nasreen, additional, Chilton, Daniella, additional, Haidari, Golaleh, additional, Simons, Rebecca, additional, Kulasegaram, Rajababu, additional, Larbalestier, Nick, additional, Nori, Achyuta, additional, Potter, Jack, additional, Tuudah, Cecilia, additional, Wade, Paul, additional, Travers, Alexandra, additional, Dunford, Sarah, additional, Greenwood, Joshua, additional, Oledimmah, Georgina, additional, Gyampo, Lesley, additional, SA Pinto, Pedro, additional, Muse, AbdulKadir, additional, Parker, Zoe, additional, Alexander, Charlotte, additional, Khan, Alexander, additional, Ajayi, Medinat, additional, Baltazar, Abigail, additional, Sharella, Davis, additional, Hersi, Nasra, additional, Nguyen, Thuy, additional, Timbo, Rugiatu, additional, Jalloh, Ismail, additional, Bryan, Susan, additional, Clarke, Patricia, additional, Kerr, Marcia, additional, Amedu, Fidelis, additional, BohoBonaba, Maria, additional, Haque, Sarah, additional, Howson, Michelle, additional, Tambilawan, Norbai, additional, Yupanqui Estay, Soledad, additional, Bangura, Hawanatu, additional, Gideon, Tseday, additional, Jerome-oboh, Damilola, additional, Tetteh, Linda, additional, Nwagu, Chioma, additional, Agbaglah, Viwoalo, additional, Narag, Nona, additional, Zaveri, Mahima, additional, Ni Luanaigh, Maedhbh, additional, Keane, Peggy, additional, Peters, Joanna, additional, Abbara, Aula, additional, Dosekun, Olamide, additional, Bolland, Mhairi, additional, Stafford, Adam, additional, Saleh, Dina, additional, Sheridan, Rhianna, additional, Davies, Ella, additional, Sun, Kristi, additional, Gilchrist, Mark, additional, Kukadia, Priti, additional, Embrahimsa, Muhammed, additional, Chiu, Christopher, additional, Taylor, Lauren, additional, Short, Charlotte, additional, Alagratnam, Jasmini, additional, Jayaweera, Iresh, additional, Gundugola, Kavitha, additional, Quinn, Killian, additional, Nic Fhogartaigh, Caoimhe, additional, Kaur, Nivenjit, additional, Bholah, Salmaan, additional, Kantha, Kajann, additional, Youngs, Jonathan, additional, Lampejo, Temi, additional, Pitto, Nicholas, additional, Lawrence, David, additional, Middleditch, Holly, additional, Dominguez-Dominguez, Lourdes, additional, Ratnappuli, Ayoma, additional, Al-Hashimi, Sara, additional, Oliveira, Amelia, additional, Ottaway, Zoe, additional, Mulka, Larissa, additional, Neary, Anne, additional, Downey, Michael, additional, Lucy, Danielle, additional, McCallum, Craig, additional, Beadsworth, Michael, additional, Ratcliffe, Libuse, additional, Fletcher, Tom, additional, Davies, Gerry, additional, Wong, Nicholas, additional, Aston, Stephen, additional, Wingfield, Thomas, additional, Blanchard, Thomas, additional, Hine, Paul, additional, Woolley, Stephen, additional, Gould, Susie, additional, Smith, Christopher, additional, Abouyannis, Michael, additional, Atomode, Abolaji, additional, Cruise, James, additional, Samual, Merna, additional, Scott, Nicola, additional, Srirathan, Vino, additional, Lewis, Joseph, additional, Richards, Lauren, additional, Cummings, Mary-Ann, additional, Gillan, Emily, additional, Peers, Rebecca, additional, Tickle, Amy, additional, Keating, Grace, additional, Chinyanda, Tendi, additional, Sanchez, Mav, additional, Harrison, Daniel, additional, Hoyle, Marie-Claire, additional, Metcalfe, Ben, additional, Taylor, Jennifer, additional, Johnson, Nicky, additional, Kelle, Neil, additional, McDowell, Kirsty, additional, Richardson, Ian, additional, Saguidan, Monette, additional, Farmer, Nicky, additional, Gillespie, Angella, additional, Willoughby, Shay, additional, Parker, Samantha, additional, Avulan, Shamseena, additional, Arif, Shazia, additional, Marshall, Suzanne, additional, Carlisle, David, additional, Rezaei, Mohsen, additional, Booth, Angela, additional, Watts, Joanne, additional, Tremarco, Lauren, additional, Jeyanayagam, Priyanga, additional, Ubochi, Odinaka, additional, Vagianos, Daniel, additional, Richardson, Mark, additional, Jarvis, Anthony, additional, Gow, Kyra, additional, Walmsley, Jade, additional, O'keefe, Adam, additional, Smielewska, Anna, additional, Hopkins, Mark, additional, Balane, Fatima, additional, Bradley, Sarah, additional, Corrah, Tumena, additional, Daquiz, Venus, additional, Dugan, Christopher, additional, Elliot, Joshua, additional, Foley, Fiona, additional, Friday, Dawn, additional, Gamit, May, additional, Garner, David, additional, Gokani, Karishma, additional, John, Laurence, additional, Joseph, Deepa, additional, Khan, Nuzhath, additional, Mamuyac, Cherifer, additional, McGregor, Alastair, additional, McSorley, John, additional, Papineni, Padmasayee, additional, Parris, Victoria, additional, Rubinstein, Luciana, additional, Rycroft, Julian, additional, Salinas, Kelcy, additional, Salinas, Jason, additional, Sebatian, Jency, additional, Smith, Melanie, additional, Tejero Garcia, Marina, additional, Ume, Uchenna, additional, Vicentine, Margarete, additional, Wallis, Gabriel, additional, Bonington, Alec, additional, Uriel, Alison, additional, Ustianowski, Andrew, additional, Dancso, Balazs, additional, Hogan, Celia, additional, van Halsema, Clare, additional, Vilar, F Javier, additional, Devine, Karen, additional, Ajdukiewicz, Katherine, additional, Rajendran, Rajesh, additional, Ghosh, Samit, additional, Riste, Michael, additional, Machin, Nicholas, additional, Babu, Chitra, additional, Ahmad, Shazaad, additional, Obeng, Dorcas, additional, Dave, Farnaz, additional, Conolley, Gavin, additional, Thompson, Joseph, additional, Tickell-Painter, Maya, additional, Chakravorty, Prasun, additional, Pringle, Rachel, additional, Zafar, Mohammad, additional, Lawrence, Sarah, additional, Sanchez-Gonzalez, Amada, additional, Fernandez, Cristina, additional, Dawson, Lynsey, additional, Carey, David, additional, Howarth-Maddison, Molly, additional, Moody, Samuel, additional, Upton, Rebecca, additional, Apthorp, Christina, additional, Murray, Charlotte, additional, Salthouse, Kirstie, additional, Nadeem, Sabah, additional, Ridley, Grant, additional, White, Francesca, additional, Brown, Andrew, additional, Lawless, Michael, additional, Mohamed, Mohamed, additional, Mulligan, Robert, additional, Belfield, Amy, additional, Brolly, Jacob, additional, Calderon, Maria, additional, Cheveau, James, additional, Cullinan, Milo, additional, Garrad, Sophie, additional, Griffiths, Will, additional, Ireland, Aidan, additional, Ireland, Peter, additional, Milne, Charlotte, additional, Nwajiugo, Paul, additional, Ghavami-Kia, Bijan, additional, Duncan, Chris, additional, Evans, Adam, additional, Hunter, Ewan, additional, Price, Ashley, additional, Schmid, Matthias, additional, Schwab, Uli, additional, Taha, Yusri, additional, Payne, Brendan, additional, Elliott, Ivo, additional, Woodrow, Charles, additional, Karageorgopoulos, Drosos, additional, Davis, Peter, additional, Lord, Emily, additional, Bannister, Oliver, additional, Dagens, Andrew, additional, Tunbridge, Anne, additional, Choudry, Saher, additional, Telfer, Adam, additional, Jhibril, Ihsan, additional, Atta, Syed, additional, Stone, Ben, additional, Evans, Cariad, additional, Ankcorn, Mike, additional, Akili, Suha, additional, Yavuz, Mehmet, additional, Goodall, Vicky, additional, Farrow, Sam, additional, Mountford, Georgina, additional, Beard, Kate, additional, Sutton, Julian, additional, Clark, Tristan, additional, Mason, Annette, additional, Vickers, Mike, additional, Macallan, Derek, additional, Bicanic, Tihana, additional, Houston, Angela, additional, Pope, Cassie, additional, Tan, NgeeKeong, additional, Ward, Christopher, additional, Cohen, Jonathan, additional, Emonts-le Clercq, Marieke, additional, Porter, David, additional, Riordan, Andrew, additional, Sinha, Ruchi, additional, and Whittaker, Elizabeth, additional

Published
2022
Full Text
View/download PDF

17. Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF

Author

McDowell, Kirsty, Welsh, Paul, Docherty, Kieran F., Morrow, David A., Jhund, Pardeep S., De Boer, Rudolf A., O’Meara, Eileen, Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Ponikowski, Piotr, Hammarstedt, Ann, Langkilde, Anna Maria, Sjöstrand, Mikaela, Lindholm, Daniel, Solomon, Scott D., Sattar, Naveed, Sabatine, Marc S., McMurray, John J.V., and Cardiovascular Centre (CVC)

Subjects
Male, Heart failure, Sodium–glucose cotransporter 2, FUROSEMIDE, EJECTION FRACTION, Ventricular Dysfunction, Left, Glucosides, Humans, Benzhydryl Compounds, Mortality, Aged, ALLOPURINOL, Sodium-glucose cotransporter 2, GOUT, POST-HOC ANALYSIS, Diabetes, XANTHINE-OXIDASE INHIBITION, Stroke Volume, ASSOCIATION, Middle Aged, CHRONIC HEART-FAILURE, DRUG INTERACTION, HYPERURICEMIA, Female, Cardiology and Cardiovascular Medicine, Uric acid
Abstract

Aims: Blood uric acid (UA) levels are frequently elevated in patients with heart failure and reduced ejection fraction (HFrEF), may lead to gout and are associated with worse outcomes. Reduction in UA is desirable in HFrEF and sodium–glucose cotransporter 2 inhibitors may have this effect. We aimed to examine the association between UA and outcomes, the effect of dapagliflozin according to baseline UA level, and the effect of dapagliflozin on UA in patients with HFrEF in the DAPA-HF trial. Methods and results: The association between UA and the primary composite outcome of cardiovascular death or worsening heart failure, its components, and all-cause mortality was examined using Cox regression analyses among 3119 patients using tertiles of UA, after adjustment for other prognostic variables. Change in UA from baseline over 12 months was also evaluated. Patients in tertile 3 (UA ≥6.8 mg/dl) versus tertile 1 (2), and more often treated with diuretics. Higher UA was associated with a greater risk of the primary outcome (adjusted hazard ratio tertile 3 vs. tertile 1: 1.32, 95% confidence interval [CI] 1.06–1.66; p = 0.01). The risk of heart failure hospitalization and cardiovascular death increased by 7% and 6%, respectively per 1 mg/dl unit increase of UA (p = 0.04 and p = 0.07). Spline analysis revealed a linear increase in risk above a cut-off UA value of 7.09 mg/dl. Compared with placebo, dapagliflozin reduced UA by 0.84 mg/dl (95% CI −0.93 to −0.74) over 12 months (p < 0.001). Dapagliflozin improved outcomes, irrespective of baseline UA concentration. Conclusion: Uric acid remains an independent predictor of worse outcomes in a well-treated contemporary HFrEF population. Compared with placebo, dapagliflozin reduced UA and improved outcomes irrespective of UA concentration.

Published
2022

21. Effects of intentional weight loss in patients with obesity and heart failure: a systematic review

Author

McDowell, Kirsty, Petrie, Mark C., Raihan, Nahian Abdur, and Logue, Jennifer

Abstract

Objective: \ud Obesity is an independent risk factor for the development of heart failure, and the two commonly co‐exist. The European Society of Cardiology does not provide guidance regarding weight loss strategies in heart failure. The aim of this study was to systematically review the evidence for outcomes following intentional weight loss in patients with heart failure and obesity.\ud \ud Method: \ud A systematic review of English articles was undertaken using databases PubMed, Embase and CENTRAL. Randomized controlled trials and observational studies reporting outcomes following intentional weight loss by lifestyle, surgical or pharmacotherapy intervention in patients with obesity and heart failure were included.\ud \ud Results: \ud Four randomized controlled trials and seven observational studies were identified. Two randomized controlled trials used diet and exercise as an intervention, one used diet alone and one used a pharmacological intervention (orlistat). All but one reported significant weight loss. Two reported improvement in exercise capacity and quality of life. One reported improvement in New York Heart Association functional class in heart failure with preserved ejection fraction. The observational studies, five of which reported on outcomes following bariatric surgery, despite being small, heterogeneous and high risk of bias, suggested a trend in improvement of left ventricular function, quality of life and exercise capacity following weight loss.\ud \ud Conclusion: \ud Weight loss is achievable with lifestyle intervention in those with heart failure and obesity and may result in improvements in New York Heart Association classification, quality of life and exercise capacity.

Published
2018

24. Falling on Deaf Ears? The Psychology of Giving Advice.

Author

McDowell, Kirsty

Subjects
ADVICE, VOLUNTEER service, DECISION making, PSYCHOLOGY
Abstract

The article focuses on the psychology of advice giving and receiving to manage and lead a group of volunteers that deals with offering information to participants, timing of advice, and decision support.

Published
2016

25. ACE-2 Downregulation and Incidence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Infection.

Author

Weir, Robin A P, Glen, Claire, and McDowell, Kirsty

Subjects
SARS-CoV-2, COVID-19, DOWNREGULATION, ANGIOTENSIN II, ACE inhibitors, ANGIOTENSIN converting enzyme, ANGIOTENSIN-receptor blockers, DIABETIC nephropathies
Abstract

If incidence and hospitalization rate is reduced, this could inform a paradigm shift in focus from ACE-2 amelioration to antagonism in the prevention/limitation of future ACE-2 mediated viral infections including SARS-CoV-2. 2 Dublin et al.'s study therefore infers, indirectly, that chronically increased ACE-2 does not predispose to SARS-CoV-2 infection or severity despite its high affinity for ACE-2. 1,2 The effect of chronically downregulated ACE-2 on susceptibility to SARS-CoV-2 is unknown. [Extracted from the article]

Published
2021
Full Text
View/download PDF

29. Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF.

Author

McDowell K, Welsh P, Docherty KF, Morrow DA, Jhund PS, de Boer RA, O'Meara E, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Hammarstedt A, Langkilde AM, Sjöstrand M, Lindholm D, Solomon SD, Sattar N, Sabatine MS, and McMurray JJV

Subjects
Aged, Benzhydryl Compounds, Female, Glucosides pharmacology, Humans, Male, Middle Aged, Stroke Volume, Uric Acid, Heart Failure complications, Ventricular Dysfunction, Left complications
Abstract

Aims: Blood uric acid (UA) levels are frequently elevated in patients with heart failure and reduced ejection fraction (HFrEF), may lead to gout and are associated with worse outcomes. Reduction in UA is desirable in HFrEF and sodium-glucose cotransporter 2 inhibitors may have this effect. We aimed to examine the association between UA and outcomes, the effect of dapagliflozin according to baseline UA level, and the effect of dapagliflozin on UA in patients with HFrEF in the DAPA-HF trial., Methods and Results: The association between UA and the primary composite outcome of cardiovascular death or worsening heart failure, its components, and all-cause mortality was examined using Cox regression analyses among 3119 patients using tertiles of UA, after adjustment for other prognostic variables. Change in UA from baseline over 12 months was also evaluated. Patients in tertile 3 (UA ≥6.8 mg/dl) versus tertile 1 (<5.4 mg/dl) were younger (66.3 ± 10.8 vs. 68 ± 10.2 years), more often male (83.1% vs. 71.5%), had lower estimated glomerular filtration rate (58.2 ± 17.4 vs. 70.6 ± 18.7 ml/min/1.73 m 2 ), and more often treated with diuretics. Higher UA was associated with a greater risk of the primary outcome (adjusted hazard ratio tertile 3 vs. tertile 1: 1.32, 95% confidence interval [CI] 1.06-1.66; p = 0.01). The risk of heart failure hospitalization and cardiovascular death increased by 7% and 6%, respectively per 1 mg/dl unit increase of UA (p = 0.04 and p = 0.07). Spline analysis revealed a linear increase in risk above a cut-off UA value of 7.09 mg/dl. Compared with placebo, dapagliflozin reduced UA by 0.84 mg/dl (95% CI -0.93 to -0.74) over 12 months (p < 0.001). Dapagliflozin improved outcomes, irrespective of baseline UA concentration., Conclusion: Uric acid remains an independent predictor of worse outcomes in a well-treated contemporary HFrEF population. Compared with placebo, dapagliflozin reduced UA and improved outcomes irrespective of UA concentration., (© 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results